Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Expert Says Vaccines Are Largely Safe for Rheumatology Patients

Thomas R. Collins  |  Issue: July 2019  |  July 18, 2019

When a rheumatologist is about to start a patient on treatment, it’s a good idea to consider vaccinations & think ahead, possibly holding a medication so the vaccine can be effective.

Zoster Vaccinations

Additionally, zoster vaccinations may become more feasible for rheumatology patients, Dr. Schwartz said.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

An inactivated zoster vaccine, Shingrix, is now available, making it a more appealing option for immunosuppressed patients than the live version. The original clinical trials excluded patients with autoimmune diseases and organ transplant recipients. But a recent, randomized, controlled trial tested this by enrolling 264 kidney transplant recipients, and the results suggest it is safe and effective in that population.2

Patients in the trial were on a calcineurin inhibitor, steroids and mycophenolate mofetil. Immune responses were higher among those randomized to receive the vaccine, compared with placebo. Local adverse events were higher, but renal function changes, rejections and potential immune-mediated diseases were no more common in the treatment group than in the placebo group.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“I think the signals are really showing that this may be fine and would be efficacious,” Dr. Schwartz said. “I’m really excited about this vaccine.”

He also emphasized the importance of the HPV vaccine. Immunosuppression promotes persistence of the human papillomavirus, which is linked to a variety of cancers.

“Vaccination can reduce these risks, particularly if it’s given before one acquires HPV,” he said. Dr. Schwartz recommends all rheumatology patients under the age of 27 get the HPV vaccine.

Vaccines for Travel

Traveling abroad involves extra risk for rheumatology patients who are immunosuppressed, and vaccinations to prevent illness are not always possible. The yellow fever shot, a live vaccine, is contraindicated in most patients. But an alternative is to use DEET products for protection during travel. Patients can also get a waiver if they will be in a yellow fever-prone area for just a short time, Dr. Schwartz noted.

The typhoid intramuscular vaccine is acceptable, Dr. Schwartz said, but the oral vaccine is live and should be avoided, he stressed. The hepatitis A vaccine is also recommended, and if travel is less than two weeks away, an immunoglobulin injection is recommended.

Dr. Schwartz suggested people with rheumatic diseases take copies of their prescriptions and identify ahead of time the best hospitals in the areas they’ll be visiting.

And he had one more piece of advice: “I recommend they spend the extra money to purchase evacuation insurance. If they have a complication, they can come home and get care from their doctors.”  

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsPractice Support Tagged with:vaccinationvaccines

Related Articles

    Vaccines & Rheumatology Patients

    June 12, 2019

    Vaccines are often safe for rheumatology patients, but precautions may be needed, said Brian Schwartz, MD, at the 2019 ACR State-of-the-Art Clinical Symposium…

    H1N1 Influenza A Virus Brings Many Questions, Few Answers

    November 1, 2009

    Rheumatologists grapple with vaccine concerns and the impact of medications on response

    The End of the Beginning: COVID-19 Vaccines & Other Conundrums

    December 9, 2020

    “It’s like winning Powerball.” For months, there has been a steady trickle of questions from my patients, asking for my opinion about the new vaccines being developed to prevent COVID-19. More to the point, they want to know if they should be vaccinated. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEAfter some fits and starts, I finally struck…

    Vaccine Hesitancy: Wariness Is Rare, But There’s a Wider Worry About COVID Vaccines’ Efficacy in Some Populations

    July 6, 2021

    Hesitancy about COVID-19 vaccination persists nationwide, although it varies among regions and sociodemographic groups.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences